COMMUNIQUÉS West-GlobeNewswire
-
New Pharmacoeconomic Analysis Finds KYZATREX® Could Cut the VA’s Total Cost of Testosterone Care by Nearly Half for America’s Veterans
28/07/2026 -
CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio
28/07/2026 -
HealthBegins Launches Online Learning Platform to Scale ‘Upstreamist’ Movement with Expert-Led Instruction and Resources
28/07/2026 -
Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents
28/07/2026 -
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
28/07/2026 -
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
28/07/2026 -
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
28/07/2026 -
Applied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP®
28/07/2026 -
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
28/07/2026 -
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
28/07/2026 -
New Survey: Digestive Side Effects Cause 41% of GLP-1 Users to Suffer in Silence, Self-Adjust, or Consider Quitting
28/07/2026 -
Enlivex Announces $400,000,000 Private Placement
28/07/2026 -
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026 -
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28/07/2026 -
STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
28/07/2026 -
Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK
28/07/2026 -
Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome
28/07/2026 -
Exagen Inc. to Participate in Upcoming Investor Conference
28/07/2026 -
Cato Healthcare Supply Strengthens Executive Leadership Team
28/07/2026
Pages